Norris Medicines Limited (BOM:524414)
India
· Delayed Price · Currency is INR 15.00
+0.71 (4.97%)
At close: Mar 10, 2026
Norris Medicines Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | -12.37 | -11.87 | -17.49 | -32.63 | -49.62 | Upgrade
|
| Depreciation & Amortization | - | 5.37 | 5.71 | 6.3 | 6.57 | 6.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.22 | - | - | - | Upgrade
|
| Other Operating Activities | - | 4.81 | 4.47 | 20.45 | 25.49 | 25.9 | Upgrade
|
| Change in Accounts Receivable | - | -3.48 | 0.4 | -0.08 | 6.96 | 9.72 | Upgrade
|
| Change in Inventory | - | 2.05 | -11.35 | -7.78 | 26.82 | -10.97 | Upgrade
|
| Change in Accounts Payable | - | 9.24 | 15.21 | 9.21 | -49.1 | 36.53 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.51 | -1.1 | 1.39 | 5.81 | -7.1 | Upgrade
|
| Operating Cash Flow | - | 5.1 | 1.7 | 12 | -10.09 | 11.14 | Upgrade
|
| Operating Cash Flow Growth | - | 200.42% | -85.85% | - | - | - | Upgrade
|
| Capital Expenditures | - | -0.19 | -0.01 | -0.3 | -0.55 | -0.88 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.91 | - | - | - | Upgrade
|
| Investment in Securities | - | -0 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 0.15 | -0.39 | 0.08 | -0.34 | 0.26 | Upgrade
|
| Investing Cash Flow | - | -0.04 | 0.51 | -0.22 | -0.89 | -0.62 | Upgrade
|
| Long-Term Debt Issued | - | - | 1.67 | 3.24 | 25.78 | 5.4 | Upgrade
|
| Long-Term Debt Repaid | - | -0.64 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.64 | 1.67 | 3.24 | 25.78 | 5.4 | Upgrade
|
| Other Financing Activities | - | -4.4 | -3.7 | -15 | -14.82 | -16.34 | Upgrade
|
| Financing Cash Flow | - | -5.04 | -2.03 | -11.76 | 10.96 | -10.94 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | 0 | Upgrade
|
| Net Cash Flow | - | 0.02 | 0.17 | 0.02 | -0.02 | -0.43 | Upgrade
|
| Free Cash Flow | - | 4.91 | 1.69 | 11.7 | -10.65 | 10.26 | Upgrade
|
| Free Cash Flow Growth | - | 191.17% | -85.58% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | 8.44% | 2.99% | 13.99% | -11.28% | 8.37% | Upgrade
|
| Free Cash Flow Per Share | - | 0.49 | 0.17 | 1.17 | -1.06 | 1.03 | Upgrade
|
| Cash Interest Paid | - | 4.4 | 3.7 | 15 | 14.82 | 16.34 | Upgrade
|
| Levered Free Cash Flow | - | 3.9 | 2.36 | 1.26 | -18.35 | 9.53 | Upgrade
|
| Unlevered Free Cash Flow | - | 6.53 | 4.65 | 10.56 | -9.14 | 19.65 | Upgrade
|
| Change in Working Capital | - | 7.3 | 3.16 | 2.75 | -9.52 | 28.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.